Bailard, Inc. Thermo Fisher Scientific Inc. Transaction History

Bailard, Inc.

$3.8 Billion
Q3 2024

A detailed history of Bailard, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Bailard, Inc. holds 1,624 shares of TMO stock, worth $833,241. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,624

Previous 6,073 73.26%

Holding current value

$833,241

Previous $3.36 Million 70.1%

% of portfolio

0.03%

Previous 0.09%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$531.86 - $624.21 $2.37 Million - $2.78 Million	-4,449 Reduced 73.26%	1,624 $1 Million
Q2 2024 Jul 25, 2024	SELL	$541.52 - $599.02 $127,798 - $141,368	-236 Reduced 3.74%	6,073 $3.36 Million
Q1 2024 May 08, 2024	SELL	$528.82 - $599.43 $57,112 - $64,738	-108 Reduced 1.68%	6,309 $3.67 Million
Q4 2023 Feb 02, 2024	SELL	$431.41 - $532.94 $9,922 - $12,257	-23 Reduced 0.36%	6,417 $3.41 Million
Q3 2023 Oct 24, 2023	SELL	$498.29 - $574.41 $18,935 - $21,827	-38 Reduced 0.59%	6,440 $3.26 Million
Q2 2023 Jul 20, 2023	SELL	$508.46 - $591.13 $17,796 - $20,689	-35 Reduced 0.54%	6,478 $3.38 Million
Q1 2023 May 08, 2023	SELL	$535.0 - $604.82 $72,760 - $82,255	-136 Reduced 2.05%	6,513 $3.75 Million
Q4 2022 Feb 02, 2023	SELL	$484.71 - $571.37 $26,659 - $31,425	-55 Reduced 0.82%	6,649 $3.66 Million
Q3 2022 Oct 18, 2022	BUY	$507.19 - $604.49 $3,043 - $3,626	6 Added 0.09%	6,704 $3.4 Million
Q2 2022 Jul 27, 2022	BUY	$500.9 - $612.21 $2,504 - $3,061	5 Added 0.07%	6,698 $3.64 Million
Q1 2022 Apr 25, 2022	SELL	$524.0 - $644.92 $14,148 - $17,412	-27 Reduced 0.4%	6,693 $3.95 Million
Q4 2021 Feb 10, 2022	BUY	$569.0 - $667.24 $147,940 - $173,482	260 Added 4.02%	6,720 $4.48 Million
Q2 2021 Aug 13, 2021	SELL	$441.0 - $508.24 $17,199 - $19,821	-39 Reduced 0.6%	6,460 $3.26 Million
Q1 2021 May 13, 2021	BUY	$439.85 - $518.83 $2.44 Million - $2.88 Million	5,552 Added 586.27%	6,499 $2.97 Million
Q4 2020 Feb 03, 2021	BUY	$435.06 - $527.66 $88,752 - $107,642	204 Added 27.46%	947 $441,000
Q3 2020 Nov 10, 2020	SELL	$359.77 - $441.52 $119,083 - $146,143	-331 Reduced 30.82%	743 $328,000
Q2 2020 Aug 12, 2020	BUY	$275.2 - $362.34 $61,094 - $80,439	222 Added 26.06%	1,074 $389,000
Q1 2020 Apr 16, 2020	SELL	$255.3 - $340.05 $160,073 - $213,211	-627 Reduced 42.39%	852 $242,000
Q4 2019 Jan 31, 2020	BUY	$271.93 - $328.04 $107,956 - $130,231	397 Added 36.69%	1,479 $480,000
Q3 2019 Oct 18, 2019	SELL	$268.46 - $305.43 $23,892 - $27,183	-89 Reduced 7.6%	1,082 $315,000
Q2 2019 Jul 26, 2019	SELL	$257.51 - $295.55 $11,330 - $13,004	-44 Reduced 3.62%	1,171 $344,000
Q1 2019 Apr 24, 2019	SELL	$212.17 - $273.72 $5,516 - $7,116	-26 Reduced 2.1%	1,215 $333,000
Q4 2018 Feb 05, 2019	SELL	$208.47 - $251.98 $74,632 - $90,208	-358 Reduced 22.39%	1,241 $278,000
Q3 2018 Nov 13, 2018	BUY	$205.57 - $244.32 $61,671 - $73,296	300 Added 23.09%	1,599 $390,000
Q2 2018 Aug 08, 2018	BUY	$203.14 - $219.53 $28,642 - $30,953	141 Added 12.18%	1,299 $269,000
Q1 2018 May 07, 2018	SELL	$192.98 - $224.11 $2.48 Million - $2.88 Million	-12,857 Reduced 91.74%	1,158 $239,000
Q4 2017 Feb 08, 2018	SELL	$182.03 - $200.37 $3.27 Million - $3.6 Million	-17,968 Reduced 56.18%	14,015 $0
Q3 2017 Oct 11, 2017	BUY	$171.74 - $194.04 $192,005 - $216,936	1,118 Added 3.62%	31,983 $6.05 Million
Q2 2017 Aug 11, 2017	BUY	N/A	777 Added 2.58%	30,865 $0
Q1 2017 Jan 29, 2018	BUY	N/A	61 Added 0.2%	30,088 $4.62 Million
Q4 2016 Jan 29, 2018	BUY	N/A	954 Added 3.28%	30,027 $0
Q3 2016 Jan 29, 2018	BUY	N/A	13,219 Added 83.38%	29,073 $4.62 Million
Q2 2016 Jan 29, 2018	BUY	N/A	15,854	15,854 $0

Others Institutions Holding TMO

# of Institutions

2,828

Shares Held

335M

Call Options Held

2.2M

Put Options Held

2.43M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $201B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.

Account